Bromocriptine-associated hyponatraemia in cirrhosis.
作者信息
Marshall A W, Jakobovits A W, Morgan M Y
出版信息
Br Med J (Clin Res Ed). 1982 Nov 27;285(6354):1534-5. doi: 10.1136/bmj.285.6354.1534.
Abstract
摘要
相似文献
1
Bromocriptine-associated hyponatraemia in cirrhosis.
Br Med J (Clin Res Ed). 1982 Nov 27;285(6354):1534-5. doi: 10.1136/bmj.285.6354.1534.
2
Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.溴隐亭成功用于治疗一名慢性门体性脑病患者。
N Engl J Med. 1977 Apr 7;296(14):793-4. doi: 10.1056/NEJM197704072961406.
3
[Treatment of acute and chronic hepatic encephalopathy in cirrhosis].[肝硬化急性和慢性肝性脑病的治疗]
Ann Gastroenterol Hepatol (Paris). 1984 May-Jun;20(3):163-6.
4
Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.溴隐亭成功用于慢性肝性脑病的治疗。
Gastroenterology. 1980 Apr;78(4):663-70.
5
Frequency of hyponatraemia and its influence on liver cirrhosis-related complications.低钠血症的发生率及其对肝硬化相关并发症的影响。
J Pak Med Assoc. 2010 Feb;60(2):116-20.
6
Bromocriptine for chronic portal systemic encephalopathy.溴隐亭治疗慢性门体性脑病
Gastroenterology. 1980 Jun;78(6):1661-2.
7
Bromocriptine-associated ototoxicity.溴隐亭相关的耳毒性。
J Laryngol Otol. 1984 Apr;98(4):399-404. doi: 10.1017/s0022215100146808.
8
Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.用溴隐亭治疗慢性门体性脑病：一项双盲对照试验。
Gastroenterology. 1979 Jun;76(6):1347-51.
9
[Cirrhosis and encephalopathy. Hyponatremia and neurologic disorders].
Med Chir Dig. 1976;5(3):147.
10
Hyponatraemia in patients with cirrhosis.肝硬化患者的低钠血症
Q J Med. 1990 Jul;76(279):675-88.
引用本文的文献
1
Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.肝性脑病的发病机制、诊断与治疗。
J Clin Exp Hepatol. 2011 Sep;1(2):77-86. doi: 10.1016/S0973-6883(11)60126-6. Epub 2011 Nov 9.
2
The treatment of hepatic encephalopathy.肝性脑病的治疗。
Metab Brain Dis. 2007 Dec;22(3-4):389-405. doi: 10.1007/s11011-007-9060-7.
3
Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.药物性抗利尿激素分泌异常综合征。病因、诊断与管理。
Drugs Aging. 1997 Jul;11(1):27-44. doi: 10.2165/00002512-199711010-00004.
4
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.多巴胺激动剂在治疗高催乳素血症及抑制泌乳方面耐受性概况的比较性综述。
Drug Saf. 1996 Apr;14(4):228-38. doi: 10.2165/00002018-199614040-00003.
5
Hyponatraemia and dopaminergic agents.低钠血症与多巴胺能药物。
Postgrad Med J. 1994 Apr;70(822):310-1. doi: 10.1136/pgmj.70.822.310.
本文引用的文献
1
Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.溴隐亭成功用于慢性肝性脑病的治疗。
Gastroenterology. 1980 Apr;78(4):663-70.
2
The effect of bromocriptine on circulating vasopressin.溴隐亭对循环血管加压素的作用。
Clin Sci (Lond). 1982 Oct;63(4):367-72. doi: 10.1042/cs0630367.
3
Aldosterone and dopamine receptors in the kidney: sites for pharmacologic manipulation of renal function.
Kidney Int. 1980 Nov;18(5):623-35. doi: 10.1038/ki.1980.180.
4
Prolactin as a regulator of fluid and electrolyte metabolism in mammals.催乳素作为哺乳动物体液和电解质代谢的调节因子。
Fed Proc. 1980 Jun;39(8):2567-70.
Zotero 插件